Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma

Figure 6

Drug sensitivity of the signature. (a) Boxplots displayed the estimated of different potential drug sensitivity (ATRA, Bleomycin, Doxorubicin, Etoposide, Nilotinib, and Tipifarnib) between low- and high-risk groups (all ). (b) Violin plots presented significant differences in the expression of individual genes across the signature in high- and low-risk groups (). (c) K-M survival curves illustrated that the lower expression of individual genes across signature had better OS ().

(a)

(b)

(c)